← Open Payments lookup

TRACY TAYLOR: Open Payments

NPI 1740405711 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,546 in 241 payments from 14 companies in 2025. Trend: 2023 $2,908 · 2024 $3,550 · 2025 $4,546

Food & beverage: $4,546
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.39$825
Neurocrine BioSciences, Inc.40$763
Teva Pharmaceuticals USA, Inc.45$659
Otsuka America Pharmaceutical, Inc.21$446
ABBVIE INC.17$379
E.R. Squibb & Sons, L.L.C.23$364
Alkermes, Inc.20$346
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$277
Lundbeck LLC12$211
Axsome Therapeutics, Inc.3$88

Products named: FANAPT, INGREZZA, REXULTI, VRAYLAR, COBENFY, AUSTEDO XR, UZEDY, CAPLYTA.

Industry payments across TX — which companies pay providers there.